Ataxin-3 plays a role in mouse myogenic differentiation through regulation of integrin subunit levels

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Costa, Maria do Carmo ^b   Bajanca, Fernanda ^a   Rodrigues, Ana João ^a   Tomé, Ricardo J ^c   Corthals, Garry ^d   Macedo Ribeiro, Sandra ^c   Paulson, Henry L ^b   Logarinho, Elsa ^a,c   Maciel, Patrícia ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PORTO   (Portugal)

^d TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ALPHA7 INTEGRIN; ATAXIN 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTOME; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE; EMBRYO, MAMMALIAN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTEGRIN ALPHA CHAINS; INTEGRIN ALPHA5; ISOELECTRIC FOCUSING; MICE; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MYOBLASTS; NUCLEAR PROTEINS; PREGNANCY; PROTEIN BINDING; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TRANSCRIPTION FACTORS;

MURINAE;

EID: 77955369713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011728     Document Type: Article

References (60)

1. Bryson-Richardson RJ, Currie PD (2008) The genetics of vertebrate myogenesis. Nat Rev Genet 9: 632-646.
2. Sporle R (2001) Epaxial-adaxial-hypaxial regionalisation of the vertebrate somite: evidence for a somitic organiser and a mirror-image duplication. Dev Genes Evol 211: 198-217.
3. Berkes CA, Tapscott SJ (2005) MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 16: 585-595.
4. Molkentin JD, Black BL, Martin JF, Olson EN (1995) Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136.
5. Luo BH, Carman CV, Springer TA (2007) Structural basis of integrin regulation and signaling. Annu Rev Immunol 25: 619-647.
6. Berrier AL, Yamada KM (2007) Cell-matrix adhesion. J Cell Physiol 213: 565-573.
7. Mayer U (2003) Integrins: redundant or important players in skeletal muscle? J Biol Chem 278: 14587-14590.
8. Kim J, Hoppe T (2006) The ubiquitin proteasome system and muscle development. In: Mayer RJ, Ciechanover AJ, Rechsteiner M, eds. Protein Degradation, Cell Biology of the Ubiquitin-Proteasome System. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA. pp 21-47.
9. Lindon C, Albagli O, Domeyne P, Montarras D, Pinset C (2000) Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain. Mol Cell Biol 20: 8923-8932.
10. Shiraishi S, Zhou C, Aoki T, Sato N, Chiba T, et al. (2007) TBP-interacting Protein 120B (TIP120B)/Cullin-associated and Neddylation-dissociated 2 (CAND2) Inhibits SCF-dependent Ubiquitination of Myogenin and Accelerates Myogenic Differentiation. J Biol Chem 282: 9017-9028.
11. Boutet SC, Disatnik MH, Chan LS, Iori K, Rando TA (2007) Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors. Cell 130: 349-362.
12. Bounpheng MA, Dimas JJ, Dodds SG, Christy BA (1999) Degradation of Id proteins by the ubiquitin-proteasome pathway. Faseb J 13: 2257-2264.
13. Matsuzawa SI, Reed JC (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7: 915-926.
14. Wu G, Xu G, Schulman BA, Jeffrey PD, Harper JW, et al. (2003) Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol Cell 11: 1445-1456.
15. Kaabeche K, Guenou H, Bouvard D, Didelot N, Listrat A, et al. (2005) Cblmediated ubiquitination of alpha5 integrin subunit mediates fibronectindependent osteoblast detachment and apoptosis induced by FGFR2 activation. J Cell Sci 118: 1223-1232.
16. Park KC, Kim JH, Choi EJ, Min SW, Rhee S, et al. (2002) Antagonistic regulation of myogenesis by two deubiquitinating enzymes, UBP45 and UBP69. Proc Natl Acad Sci USA 99: 9733-9738.
17. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, et al. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123: 773-786.
18. Chow MKM, Mackay JP, Whisstock JC, Scanlon MJ, Bottomley SP (2004) Structural and functional analysis of the josephin domain of the polyglutamine protein ataxin-3. Biochemical and Biophysical Research Communications 322: 387-394.
19. Nicastro G, Menon RP, Masino L, Knowles PP, McDonald NQ, et al. (2005) The solution structure of the josephin domain of ataxin-3: structural determinants for molecular recognition. Proceedings of the National Academy of Science USA 102: 10493-40498.
20. Mao Y, Senic-Matuglia F, Di Fiore PP, Polo S, Hodsdon ME, et al. (2005) Deubiquitinating function of ataxin-3: insights from the solution structure of the josephin domain. Proceedings of the National Academy of Science USA 102: 12700-12705.
21. Doss-Pepe EW, Stenroos ES, Johnson WG, Madura K (2003) Ataxin-3 interactions with Rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitinmediated proteolysis. Molecular and Cellular Biology 23: 6469-6483.
22. Chai Y, Berke SS, Cohen RE, Paulson HL (2004) Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. The Journal of Biological Chemistry 279: 3605-3611.
23. Burnett BG, Li F, Pittman RN (2003) The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Human Molecular Genetics 12: 3195-3205.
24. Berke SJS, Chai Y, Marrs GL, Wen H, Paulson HL (2005) Defining the role of ubiquitin interacting motifs in the polyglutamine disease protein, ataxin-3. The Journal of Biological Chemistry 280: 32026-32034.
25. Ferro A, Carvalho AL, Teixeira-Castro A, Almeida C, Tomé RL, et al. (2007) NEDD8: a new ataxin-3 interactor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1773: 1619-1627.
26. Wang H, Jia N, Fei E, Wang Z, Liu C, et al. (2007) p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome. J Neurochem.
27. Wang Q, Li L, Ye Y (2006) Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J Cell Biol 174: 963-971.
28. Zhong X, Pittman RN (2006) Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum Mol Genet 15: 2409-2420.
29. Rodrigues A-J, Neves-Carvalho A, Ferro A, Rokka A, Corthals G, et al. (2009) ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in C. elegans. Biochemical Biophysical Research Communications 386: 575-581.
30. Schols L, Bauer P, Schmidt T, Schulte T, Riess O (2004) Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3: 291-304.
31. Coutinho P, Andrade C (1978) Autosomal dominant system degeneration in Portuguese families of the Azores Islands: a new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology 28: 703-709.
32. Nakano KK, Dawson DM, Spence A (1972) Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts. Neurology 22: 49-55.
33. Rosenberg RN, Nyhan WL, Bay C, Shore P (1976) Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 26: 703-714.
34. Costa MC, Gomes-da-Silva J, Miranda CJ, Sequeiros J, Santos MM, et al. (2004) Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene. Genomics 84: 361-373.
35. Wang G-H, Sawai N, Kotliarova S, Kanazawa I, Nukina N (2000) Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Human Molecular Genetics 9: 1795-1803.
36. Tomczak KK, Marinescu VD, Ramoni MF, Sanoudou D, Montanaro F, et al. (2004) Expression profiling and identification of novel genes involved in myogenic differentiation. Faseb J 18: 403-405.
37. Gales L, Cortes L, Almeida C, Melo CV, Costa MC, et al. (2005) Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. J Mol Biol 353: 642-654.
38. Todi SV, Winborn BJ, Scaglione KM, Blount JR, Travis SM, et al. (2009) Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin- 3. Embo J 28: 372-382.
39. Tzvetkov N, Breuer P (2007) Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes. Biol Chem 388: 973-978.
40. Rodrigues AJ, Coppola G, Santos C, Costa MC, Ailion M, et al. (2007) Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. Faseb Journal 21: 1126-1136.
41. Lee HJ, Kim MS, Shin JM, Park TJ, Chung HM, et al. (2006) The expression patterns of deubiquitinating enzymes, USP22 and Usp22. Gene Expr Patterns 6: 277-284.
42. Gousseva N, Baker RT (2003) Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69. Gene Expr 11: 163-179.
43. Bajanca F, Luz M, Duxson MJ, Thorsteinsdottir S (2004) Integrins in the mouse myotome: developmental changes and differences between the epaxial and hypaxial lineage. Dev Dyn 231: 402-415.
44. Gullberg D, Velling T, Lohikangas L, Tiger CF (1998) Integrins during muscle development and in muscular dystrophies. Front Biosci 3: D1039-1050.
45. Cachaco AS, Pereira CS, Pardal RG, Bajanca F, Thorsteinsdottir S (2005) Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse. Dev Dyn 232: 1069-1078.
46. Noren NK, Pasquale EB (2004) Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal 16: 655-666.
47. Geerts D, Fontao L, Nievers MG, Schaapveld RQ, Purkis PE, et al. (1999) Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. J Cell Biol 147: 417-434.
48. Spurny R, Abdoulrahman K, Janda L, Runzler D, Kohler G, et al. (2007) Oxidation and nitrosylation of cysteines proximal to the intermediate filament (IF)-binding site of plectin: effects on structure and vimentin binding and involvement in IF collapse. J Biol Chem 282: 8175-8187.
49. Shen L, Tang BS, Tang JG, Jiang H, Wang C, et al. (2006) [Screening forproteins interacting with ataxin-3, the gene product of SCA3/MJD]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31: 40-44.
50. Sun J, Barbieri JT (2004) ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor. J Biol Chem 279: 42936-42944.
51. Eisenmann KM, McCarthy JB, Simpson MA, Keely PJ, Guan JL, et al. (1999) Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol 1: 507-513.
52. Zhang X, Jiang G, Cai Y, Monkley SJ, Critchley DR, et al. (2008) Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat Cell Biol 10: 1062-1068.
53. Schmitt I, Linden M, Khazneh H, Evert BO, Breuer P, et al. (2007) Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. Biochem Biophys Res Commun 362: 734-739.
54. Hynes RO (1996) Targeted mutations in cell adhesion genes: what have we learned from them? Dev Biol 180: 402-412.
55. Fukushige T, Brodigan TM, Schriefer LA, Waterston RH, Krause M (2006) Defining the transcriptional redundancy of early bodywall muscle development in C. elegans: evidence for a unified theory of animal muscle development. Genes Dev 20: 3395-3406.
56. Kafri R, Levy M, Pilpel Y (2006) The regulatory utilization of genetic redundancy through responsive backup circuits. Proc Natl Acad Sci USA 103: 11653-11658.
57. Rudnicki MA, Jaenisch R (1995) The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17: 203-209.
58. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, et al. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genetics 8: 221-228.
59. Webb DJ, Zhang H, Majumdar D, Horwitz AF (2007) alpha5 integrin signaling regulates the formation of spines and synapses in hippocampal neurons. J Biol Chem 282: 6929-6935.
60. Khan LA, Bauer PO, Miyazaki H, Lindenberg KS, Landwehrmeyer BG, et al. (2006) Expanded polyglutamines impair synaptic transmission and ubiquitinproteasome system in Caenorhabditis elegans. J Neurochem 98: 576-587.